// App-Quantinova.ai

TCT-191 : Long-term Outcomes Of The New Generation Drug-Eluting Stents In Patients With Diabetes Mellitus And Single Vessel Disease

Researchers

Presenter

  • Chrysoula Patsa

Principal Investigators

  • Konstantinos Toutouzas

  • Eleftherios Tsiamis

  • Anastasios Spanos

  • Tolis Hlias

  • Konstantinos P. Tsioufis

  • Dimitrios Tousoulis

  • Christodoulos Stefanadis

Medical Centers

  • Hippokratio Hospital, Athens, Greece

  • Athens Medical Center, Attiki, Greece

  • Hippokratio Hospital, Athens, Greece

Locations

  • Greece

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Myocardial infarction

  • Diabetes

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • ZoMaxx

  • Everolimus

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved